A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma

NCT00002262 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Sarcoma, Kaposi
HIV Infections

Interventions

DRUG: Tumor Necrosis Factor

Sponsor

University of California, San Francisco